Coenzyme Q10 has long been marketed as a powerful antioxidant, but emerging evidence reveals a more fundamental function that deserves clinical attention. CoQ10 serves as the only mobile electron carrier in the mitochondrial electron transport chain—a role far more critical than its antioxidant properties for sustaining ATP production and cellular energy.
A significant concern has surfaced for the millions of patients taking statin medications. A meta-analysis of 12 randomized controlled trials involving 1,776 participants demonstrates that statins significantly deplete circulating CoQ10 levels, regardless of statin type or dosage. This occurs because statins and CoQ10 share the same mevalonate synthesis pathway—meaning the same mechanism that lowers cholesterol simultaneously reduces CoQ10 availability.
The clinical implications are particularly relevant for older patients on long-term cholesterol therapy, where age-related CoQ10 decline compounds statin-induced depletion. Healthcare providers may need to consider CoQ10 monitoring and supplementation strategies in this vulnerable population.
Read the full article on GMJ Newsroom.
Was this article helpful?
